Supreme Court: Vacancies From Resignations under CUSAT Act Must Follow Communal Rotation  ||  Supreme Court: Forest Land Cannot Be Leased or Used For Agriculture Without Centre’s Approval  ||  Supreme Court: Gravity of Offence and Accused’s Role Must Guide Suspension of Sentence under CrPC  ||  Supreme Court: Arbitral Awards Cannot be Set Aside For Mere Legal Errors or Misreading of Evidence  ||  SC Acknowledges Child Trafficking as a Grave Reality and Issues Guidelines to Assess Victim Evidence  ||  Allahabad HC: When Parties Extend an Agreement by Conduct, The Arbitration Clause Extends Too  ||  Supreme Court: Issues of Party Capacity and Maintainability Must Be Decided by Arbitral Tribunal  ||  Supreme Court: Omissions in Chief Examination Can Be Rectified During Cross-Examination  ||  Supreme Court: Items Given by Accused to Police Are Not Section 27 Recoveries under Evidence Act  ||  Gujarat High Court: Waqf Institutions Must Pay Court Fees When Filing Disputes in State Tribunal    

DGFT Changes Export Policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients - (15 Jun 2021)

CIVIL

Director-General of Foreign Trade (DGFT) has notified the changes in the Export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients from ‘Prohibited’ to ‘Restricted’. Further, export of Injection Remdesivir and Remdesivir API against Advance Authorizations issued under Chapter 4 of Foreign Trade Policy/Handbook of Procedures shall not require separate export authorization or permission.

Tags : DIRECTOR-GENERAL OF FOREIGN TRADE   EXPORT POLICY OF INJECTION REMDESIVIR AND REMDESIVIR ACTIVE PHARMACEUTICAL INGREDIENTS  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved